Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
FL.37NCorman-NGAGGAACGAGAAGAGGCTTG20552883328814R-22527.5Germany
XBB.1.45.1NCorman-NGAGGAACGAGAAGAGGCTTG20552883328814R-22527.5Germany
FP.4NCorman-NGAGGAACGAGAAGAGGCTTG20552883328814R-22527.5Germany
XBB.1.5.102NCorman-NGAGGAACGAGAAGAGGCTTG20552883328814R-22527.5Germany
FK.1.3NCorman-NGAGGAACGAGAAGAGGCTTG20552883328814R-22527.5Germany
GN.5NCorman-NGAGGAACGAGAAGAGGCTTG20552883328814R-22527.5Germany
FL.31NCorman-NGAGGAACGAGAAGAGGCTTG20552883328814R-22527.5Germany
HL.1NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-18526.8US
XCDNUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-20656.7US
XBB.1.44.1NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-20656.7US
EG.2.1NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-18526.8US
FL.37NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-18526.8US
XBB.1.45.1NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-15625.1US
FP.4NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-20656.7US
XBB.1.5.102NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-20656.7US
FK.1.3NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-20656.7US
GN.5NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-20656.7US
FL.31NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-18526.8US
FL.35.1NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-18526.8US
GE.1.2NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-20656.7US
HE.1NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-20656.7US
XBB.1.33NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-20656.7US
FY.4.1.1NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-18526.8US
XBB.1.5.99NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-20656.7US
HW.1NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-20656.7US
XBB.1.4.2NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-20656.7US
FE.1.1.1NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-18526.8US
HA.1NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-20656.7US
GM.3.1NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-20656.7US
FT.3.1NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-20656.7US
JD.1.2NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-20656.7US
GJ.2NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-20656.7US
HT.1NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-20656.7US
FL.20NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-713.74US
JH.1NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-20656.7US
CK.1.1.1NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-20656.7US
XBB.1.34.2NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-20656.7US
EG.2.5NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-18526.8US
JK.1NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-20656.7US
FL.13.3NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-713.74US
EG.7NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-18526.8US
BN.1.3.5NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-20656.7US
XCF.1NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-20656.7US
XCCNUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-18526.8US
FK.1.5NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-20656.7US
FL.21.1NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-18526.8US
FP.2.1NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-20656.7US
XBB.1.5.92NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-20656.7US
XBB.1.5.42NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-20656.7US
XBB.1.5.106NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-20656.7US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used